Jefferies raised the firm’s price target on Corteva (CTVA) to $92 from $80 and keeps a Buy rating on the shares. Corteva’s multiple expansion can continue, argues the analyst, who says the rally in fertilizer prices coinciding with the end of destocking in crop chemicals stands in “sharp contrast” to the second half demand risks for industrial-sensitive chemicals and that Corteva’s leverage to increasing global acreage is a contrast to the concerns petrochemicals face over competitor supply additions. The case for the stock rising to greater than $100 near-term, and performance longer-term, hinges on a mix of policy, technology and company initiatives lifting margins and free cash flow conversion, the analyst added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva Positioned for Growth: Buy Rating Backed by Market Resilience and Strategic Advantages
- Corteva upgraded to Positive from Negative view at BWG Global
- FMC, Corteva Agriscience collaborate on fluindapyr fungicide technology
- Trump Trade: Trump considers 50% tariff on EU, 25% on iPhones
- Trump admin report implies companies are worsening health of children, FT says
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue